Opioids - MM+M - Medical Marketing and Media

Opioids

All articles by Opioids

Five things for pharma marketers to know: Thursday, January 18, 2018
Five things for pharma marketers to know: Thursday, January 18, 2018
Virginia Lau
January 18, 2018
11:00 am

Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution

Five things for pharma marketers to know: Thursday, January 11, 2018
Five things for pharma marketers to know: Thursday, January 11, 2018
Virginia Lau
January 11, 2018
3:20 pm

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Five things for pharma marketers to know: Friday, January 5, 2018
Five things for pharma marketers to know: Friday, January 5, 2018
Virginia Lau
January 5, 2018
3:25 pm

Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise

Five things for pharma marketers to know: Thursday, December 28, 2017
Five things for pharma marketers to know: Thursday, December 28, 2017
Virginia Lau
December 28, 2017
3:45 pm

Study: male docs earn more than female peers; new Michigan law tackles opioid crisis; study: some docs billed Medicare for most expensive patient visit type

Five things for pharma marketers to know: Friday, December 1, 2017
Five things for pharma marketers to know: Friday, December 1, 2017
Virginia Lau
December 1, 2017
3:40 pm

FDA approves first Apple Watch health accessory; medical charity shared data with pharma donors; FDA approves opioid-addiction treatment

Five things for pharma marketers to know: Thursday, November 30, 2017
Five things for pharma marketers to know: Thursday, November 30, 2017
Kevin McCaffrey
November 30, 2017
3:17 pm

FDA releases information on Exondys 51; Sanofi’s dengue vaccine faces new restrictions; Kellyanne Conway named opioid czar

Limits on pharma payments to doctors back on policy menu
Limits on pharma payments to doctors back on policy menu
Marc Iskowitz
November 8, 2017
2:00 pm

A mini wave of state-level rule-making has thrust the issue of restrictions on pharma payments to medical professionals back into the spotlight.

Five things for pharma marketers to know: Tuesday, November 7, 2017
Five things for pharma marketers to know: Tuesday, November 7, 2017
Virginia Lau
November 7, 2017
3:20 pm

Senator investigates Alkermes’ opioid-marketing tactics; FDA approves Roche cancer drugs; CVS to launch next-day delivery nationwide

CDC tells opioid addiction stories with message: ‘It only takes a little to lose a lot’
CDC tells opioid addiction stories with message: ‘It only takes a little to lose a lot’
Alison Kanski
November 6, 2017
7:15 pm

The CDC has launched the first wave of its awareness campaign about prescription opioids.

Five things for pharma marketers to know: Tuesday, October 31, 2017
Five things for pharma marketers to know: Tuesday, October 31, 2017
Virginia Lau
October 31, 2017
2:37 pm

Pfizer Q3 revenue driven by Prevnar sales; President Trump’s opioid panel presents draft to combat crisis; Novartis seeks FDA approval for CAR-T therapy Kymriah

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners